113 related articles for article (PubMed ID: 26742439)
1. Production and Characterization of New Anti-Human CD20 Monoclonal Antibody.
Fasihi-Ramandi M; Amani J; Salmanian A; Moazzeni S; Ahmadi K
Iran J Allergy Asthma Immunol; 2015 Oct; 14(5):502-8. PubMed ID: 26742439
[TBL] [Abstract][Full Text] [Related]
2. Development and Characterization of a New Antipeptide Monoclonal Antibody Directed to Human CD20 Antigen.
Habibi-Anbouhi M; Azadmanesh K; Behdani M; Hajizadeh-Saffar E; Vahabpour R; Shokrgozar MA
Cancer Biother Radiopharm; 2015 Sep; 30(7):310-6. PubMed ID: 26352927
[TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of monoclonal antibodies against the extracellular domain of B-lymphocyte antigen CD20 using DNA immunization method.
Khademi F; Mostafaie A; Parvaneh S; Gholami Rad F; Mohammadi P; Bahrami G
Int Immunopharmacol; 2017 Feb; 43():23-32. PubMed ID: 27939822
[TBL] [Abstract][Full Text] [Related]
4. Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas.
Ben Abdelwahed R; Donnou S; Ouakrim H; Crozet L; Cosette J; Jacquet A; Tourais I; Fournès B; Gillard Bocquet M; Miloudi A; Touitou V; Daussy C; Naud MC; Fridman WH; Sautès-Fridman C; Urbain R; Fisson S
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3657-65. PubMed ID: 23611989
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-linked immunosorbent assay and flow cytometric methods to screen hybridoma culture supernatants for antibodies to bovine neutrophil surface antigens, and monoclonal antibody production and characterization.
Salgar SK; Paape MJ; Alston-Mills B
Am J Vet Res; 1993 Sep; 54(9):1415-25. PubMed ID: 8239127
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of monoclonal antibodies against human CD20 in Balb/c mice.
Sepehr KS; Baradaran B; Majidi J; Abdolalizadeh J; Aghebati L; Shahneh FZ
Hum Antibodies; 2012; 21(3-4):57-64. PubMed ID: 23549022
[TBL] [Abstract][Full Text] [Related]
7. Identification of a candidate therapeutic antibody for treatment of canine B-cell lymphoma.
Rue SM; Eckelman BP; Efe JA; Bloink K; Deveraux QL; Lowery D; Nasoff M
Vet Immunol Immunopathol; 2015 Apr; 164(3-4):148-59. PubMed ID: 25764941
[TBL] [Abstract][Full Text] [Related]
8. Novel anti-CD20 antibody TGLA with enhanced antibody-dependent cell-mediated cytotoxicity mediates potent anti-lymphoma activity.
Lv M; Lin Z; Qiao C; Gen S; Lang X; Li Y; Feng J; Shen B
Cancer Lett; 2010 Aug; 294(1):66-73. PubMed ID: 20202740
[TBL] [Abstract][Full Text] [Related]
9. [Apoptosis of human B cell lymphoma Raji cells induced by monovalent anti-CD20 antibody].
Liu YX; Fan DM; Xiong DS; Xu YF; Shao XF; Xu YS; Peng H; Yang M; Qin L; Zhu ZP; Yang CZ
Ai Zheng; 2003 Dec; 22(12):1249-53. PubMed ID: 14693045
[TBL] [Abstract][Full Text] [Related]
10. Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells.
Liu C; DeNardo G; Tobin E; DeNardo S
Cancer Biother Radiopharm; 2004 Oct; 19(5):545-61. PubMed ID: 15650447
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human B-cell lymphoma by an anti-CD20 antibody and its chimeric F(ab')2 fragment via induction of apoptosis.
Liu Y; Zheng M; Lai Z; Xiong D; Fan D; Xu Y; Peng H; Shao X; Xu Y; Yang M; Wang J; Liu H; Xie Y; Yang C; Zhu Z
Cancer Lett; 2004 Mar; 205(2):143-53. PubMed ID: 15036646
[TBL] [Abstract][Full Text] [Related]
12. [Preclinical study of apoptosis of B-NHL cell lines induced by anti-CD20 monoclonal antibody].
Zhang HY; Chen HT; Guan ZZ; Huang Y; Zhang X; Lin TY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):883-7. PubMed ID: 19698222
[TBL] [Abstract][Full Text] [Related]
13. Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20.
Maddipatla S; Hernandez-Ilizaliturri FJ; Knight J; Czuczman MS
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4556-64. PubMed ID: 17671142
[TBL] [Abstract][Full Text] [Related]
14. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
[TBL] [Abstract][Full Text] [Related]
15. In silico designing, cloning, and heterologous expression of novel chimeric human B lymphocyte CD20 extra loop.
Fasihi-Ramandi M; Amani J; Salmanian AH; Moazzeni SM; Ahmadi K
Tumour Biol; 2016 Sep; 37(9):12547-12553. PubMed ID: 27350367
[TBL] [Abstract][Full Text] [Related]
16. Mimotope vaccination for epitope-specific induction of anti-CD20 antibodies.
Li M; Yan Z; Han W; Zhang Y
Cell Immunol; 2006 Feb; 239(2):136-43. PubMed ID: 16814270
[TBL] [Abstract][Full Text] [Related]
17. The Construction and Characterization of 1F5 Chimeric Anti-CD20 Monoclonal Antibodies: An Efficient Splicing by Overlap Extension-polymerase Chain Reaction Technique.
Khademi F; Mohammadi P; Mostafaei A
Iran J Allergy Asthma Immunol; 2021 Apr; 20(2):205-220. PubMed ID: 33904679
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of monoclonal antibodies to Chlamydia trachomatis.
Kumar A; Mittal A
Hybridoma (Larchmt); 2006 Oct; 25(5):293-9. PubMed ID: 17044785
[TBL] [Abstract][Full Text] [Related]
19. Selection of an anti-CD20, single-chain antibody by phage ELISA on fixed cells.
Schmidt S; Braunagel M; Kürschner T; Little M
Biotechniques; 1999 Apr; 26(4):697-702. PubMed ID: 10343908
[TBL] [Abstract][Full Text] [Related]
20. CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphoma.
Palomba ML; Roberts WK; Dao T; Manukian G; Guevara-Patiño JA; Wolchok JD; Scheinberg DA; Houghton AN
Clin Cancer Res; 2005 Jan; 11(1):370-9. PubMed ID: 15671568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
